2023 - Research.com Medicine in Japan Leader Award
His primary areas of study are Internal medicine, Stroke, Cohort study, Risk factor and Prospective cohort study. His study in Internal medicine is interdisciplinary in nature, drawing from both Diabetes mellitus and Endocrinology. His Stroke study incorporates themes from Epidemiology, Surgery, Vascular disease, Disease and Hazard ratio.
His Cohort study research includes elements of Overweight, Food science, Gerontology and Environmental health. His Risk factor research focuses on Incidence and how it connects with Myocardial infarction and Heart disease. His study in Prospective cohort study is interdisciplinary in nature, drawing from both Odds ratio, Physiology and Intraparenchymal hemorrhage.
Hiroyasu Iso spends much of his time researching Internal medicine, Prospective cohort study, Cohort study, Stroke and Hazard ratio. His Internal medicine research is multidisciplinary, incorporating elements of Endocrinology and Cardiology. The various areas that he examines in his Prospective cohort study study include Incidence, Intraparenchymal hemorrhage, Lower risk, Public health and Cohort.
His studies deal with areas such as Cancer, Gerontology, Environmental health, Relative risk and Obstetrics as well as Cohort study. His Stroke study combines topics from a wide range of disciplines, such as Coronary heart disease, Surgery, Epidemiology, Disease and Physical therapy. The Hazard ratio study combines topics in areas such as Risk of mortality and Proportional hazards model.
His primary scientific interests are in Internal medicine, Cohort study, Prospective cohort study, Hazard ratio and Confidence interval. His Internal medicine study frequently involves adjacent topics like Cardiology. His work carried out in the field of Cohort study brings together such families of science as Body mass index, Cancer, Incidence, Environmental health and Obstetrics.
As a part of the same scientific family, Hiroyasu Iso mostly works in the field of Prospective cohort study, focusing on Pregnancy and, on occasion, Autism. His Hazard ratio research is multidisciplinary, relying on both Absolute risk reduction, Diabetes mellitus, Lower risk, Proportional hazards model and Confounding. The Stroke study which covers Disease that intersects with Epidemiology and Global health.
Hiroyasu Iso focuses on Prospective cohort study, Cohort study, Internal medicine, Stroke and Hazard ratio. His Prospective cohort study study combines topics in areas such as Cause specific mortality, Proportional hazards model, Linear regression and Medical record. Hiroyasu Iso combines subjects such as Incidence, Environmental health, Adverse effect, Public health and Type 2 diabetes with his study of Cohort study.
His work investigates the relationship between Internal medicine and topics such as Alcohol that intersect with problems in Social support. Hiroyasu Iso has researched Stroke in several fields, including Coronary heart disease, Intraparenchymal hemorrhage, Blood pressure, Disease and Myocardial infarction. His work in Hazard ratio addresses issues such as Risk of mortality, which are connected to fields such as Aneurysm, Aortic aneurysm and Kidney disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Theo Vos;Theo Vos;Theo Vos;Stephen S. Lim;Cristiana Abbafati;Cristiana Abbafati;Cristiana Abbafati;Kaja M. Abbas;Kaja M. Abbas;Kaja M. Abbas.
(2020)
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Christopher J.L. Murray;Christopher J.L. Murray;Christopher J.L. Murray;Aleksandr Y. Aravkin;Aleksandr Y. Aravkin;Aleksandr Y. Aravkin;Peng Zheng;Peng Zheng;Peng Zheng;Cristiana Abbafati;Cristiana Abbafati;Cristiana Abbafati.
(2020)
Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial
Hiroyasu Iso;David R. Jacobs;Deborah Wentworth;James D. Neaton.
The New England Journal of Medicine (1989)
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
J Danesh;S Lewington;S G Thompson;Lowe Gdo..
JAMA (2005)
C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
Stephen Kaptoge;Emanuele Di Angelantonio;Lisa Pennells;Angela M. Wood.
The New England Journal of Medicine (2012)
Report of the Conference on Low Blood Cholesterol: Mortality Associations.
D Jacobs;H Blackburn;M Higgins;D Reed.
Circulation (1992)
Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I.
Hiroyasu Iso;Minatsu Kobayashi;Junko Ishihara;Satoshi Sasaki.
Circulation (2006)
Intake of fish and omega-3 fatty acids and risk of stroke in women.
Hiroyasu Iso;Kathryn M. Rexrode;Meir J. Stampfer;JoAnn E. Manson.
JAMA (2001)
Association of Cardiometabolic Multimorbidity With Mortality
Emanuele Di Angelantonio;Stephen Kaptoge;David Wormser;Peter Willeit.
JAMA (2015)
The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults
Hiroyasu Iso;Hiroyasu Iso;Chigusa Date;Chigusa Date;Kenji Wakai;Mitsuru Fukui.
Annals of Internal Medicine (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Hokkaido University
National Cancer Research Institute, UK
University of Tokyo
University of Tokyo
National Cancer Research Institute, UK
Keio University
Nagoya University
University of Minnesota
Shiga University of Medical Science
University College London
University of Zaragoza
University of Windsor
IBM (United States)
Casa Sollievo della Sofferenza
Weizmann Institute of Science
University of Nantes
Institut Pasteur
National Institutes of Health
National Taiwan University
University College Cork
Commonwealth Scientific and Industrial Research Organisation
Pacific Northwest National Laboratory
Colorado State University
Heidelberg University
BI Norwegian Business School
University of Washington